Vertex’s next act: a billion-dollar bet on a cure for type 1 diabetes
CRAIG F. WALKER/THE BOSTON GLOBE
The Cambridge, Mass., company announced it is buying Semma Therapeutics, a nearby firm turning stem cells into insulin factories.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario